Approaches to vaccines against Orientia tsutsugamushi

Scrub typhus is a severe mite-borne infection caused by Orientia tsutsugamushi, an obligately intracellular bacterium closely related to Rickettsia. The disease explains a substantial proportion of acute undifferentiated febrile cases that require hospitalization in rural areas of Asia, the North o...

Full description

Bibliographic Details
Main Authors: Gustavo eValbuena, David H Walker
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00170/full
id doaj-1df9353820854190b9789a2ce8322428
record_format Article
spelling doaj-1df9353820854190b9789a2ce83224282020-11-24T22:14:36ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882013-01-01210.3389/fcimb.2012.0017038846Approaches to vaccines against Orientia tsutsugamushiGustavo eValbuena0David H Walker1University of Texas Medical BranchUniversity of Texas Medical BranchScrub typhus is a severe mite-borne infection caused by Orientia tsutsugamushi, an obligately intracellular bacterium closely related to Rickettsia. The disease explains a substantial proportion of acute undifferentiated febrile cases that require hospitalization in rural areas of Asia, the North of Australia, and many islands of the Pacific ocean. Delayed antibiotic treatment is common due to the lack of effective commercially available diagnostic tests and the lack of specificity of the early clinical presentation. The systemic infection of endothelial cells that line the vasculature with Orientia can lead to many complications and fatalities. In survivors, immunity does not last long, and is poorly cross-reactive among numerous strains. In addition, chronic infections are established in an unknown number of patients. All those characteristics justify the pursuit of a prophylactic vaccine against O. tsutsugamushi; however, despite continuous efforts to develop such a vaccine since World War II, the objective has not been attained. In this review, we discuss the history of vaccine development against Orientia to provide a clear picture of the challenges that we continue to face from the perspective of animal models and the immunological challenges posed by an intracellular bacterium that normally triggers a short-lived immune response. We finish with a proposal for development of an effective and safe vaccine for scrub typhus through a new approach with a strong focus on T cell-mediated immunity, empirical testing of the immunogenicity of proteins encoded by conserved genes, and assessment of protection in relevant animal models that truly mimic human scrub typhus.http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00170/fullImmunityOrientia tsutsugamushiVaccinesAnimal Modelsscrub typhus.
collection DOAJ
language English
format Article
sources DOAJ
author Gustavo eValbuena
David H Walker
spellingShingle Gustavo eValbuena
David H Walker
Approaches to vaccines against Orientia tsutsugamushi
Frontiers in Cellular and Infection Microbiology
Immunity
Orientia tsutsugamushi
Vaccines
Animal Models
scrub typhus.
author_facet Gustavo eValbuena
David H Walker
author_sort Gustavo eValbuena
title Approaches to vaccines against Orientia tsutsugamushi
title_short Approaches to vaccines against Orientia tsutsugamushi
title_full Approaches to vaccines against Orientia tsutsugamushi
title_fullStr Approaches to vaccines against Orientia tsutsugamushi
title_full_unstemmed Approaches to vaccines against Orientia tsutsugamushi
title_sort approaches to vaccines against orientia tsutsugamushi
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2013-01-01
description Scrub typhus is a severe mite-borne infection caused by Orientia tsutsugamushi, an obligately intracellular bacterium closely related to Rickettsia. The disease explains a substantial proportion of acute undifferentiated febrile cases that require hospitalization in rural areas of Asia, the North of Australia, and many islands of the Pacific ocean. Delayed antibiotic treatment is common due to the lack of effective commercially available diagnostic tests and the lack of specificity of the early clinical presentation. The systemic infection of endothelial cells that line the vasculature with Orientia can lead to many complications and fatalities. In survivors, immunity does not last long, and is poorly cross-reactive among numerous strains. In addition, chronic infections are established in an unknown number of patients. All those characteristics justify the pursuit of a prophylactic vaccine against O. tsutsugamushi; however, despite continuous efforts to develop such a vaccine since World War II, the objective has not been attained. In this review, we discuss the history of vaccine development against Orientia to provide a clear picture of the challenges that we continue to face from the perspective of animal models and the immunological challenges posed by an intracellular bacterium that normally triggers a short-lived immune response. We finish with a proposal for development of an effective and safe vaccine for scrub typhus through a new approach with a strong focus on T cell-mediated immunity, empirical testing of the immunogenicity of proteins encoded by conserved genes, and assessment of protection in relevant animal models that truly mimic human scrub typhus.
topic Immunity
Orientia tsutsugamushi
Vaccines
Animal Models
scrub typhus.
url http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00170/full
work_keys_str_mv AT gustavoevalbuena approachestovaccinesagainstorientiatsutsugamushi
AT davidhwalker approachestovaccinesagainstorientiatsutsugamushi
_version_ 1725798091336974336